Johnson & Johnson gained Inlexzo, formerly known as TAR-200, when it acquired privately held Taris Biomedical in 2019. The deal gave J&J a treatment it says could change way the “non-muscle invasive” ...
As a urologist I'm seeing teenagers with bladders so damaged they need the kind of major reconstructive surgery I'd normally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback